Article
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain.
Psychopharmacology - 1 Apr 2023
Schreyer Korbinian Felix, Leucht Stefan, Heres Stephan, Steimer Werner
Abstract excerpt
RATIONALE: Weight gain is a frequent side effect of treatment with SGAs (second-generation antipsychotics) and a leading cause for nonadherence. Several candidate genes have been identified that could influence the amount of AIWG (antipsychotic-induced weight gain). The polymorphism rs17782313 near the MC4R (human melanocortin 4 receptor gene) was strongly associated with obesity in a large scale GWAS (genome...
Topics
- Humans
- Amisulpride
- Antipsychotic Agents
- Genome-Wide Association Study
- Olanzapine
- Polymorphism, Single Nucleotide
- Weight Gain
